← SynDRA
STROPHANTHIDIN
SynDRA canonical compound SYN0004146 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ATP1A1 |
|---|
| Mechanism of action | ATPase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ATAD5
- ATXN2
- TP53
- TDP1
- SMAD3
- SLCO1B3
- SLCO1B1
- RAB9A
- PAX8
- NPC1
- NFE2L2
- IDH1
- GMNN
- GLP1R
- ERG
- CBX1
- BRCA1
- TSHR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- BARD1
- CFTR
- TR10B
- STK33
- OPRM
- OPRD
- NR5A2
- NCOA3
- NCOA2
- NCOA1
- MITF
- MDR1
- MDM4
- MDM2
- IL1B
- IFNG
- IDHC
- HIF1A
- GEMI
- GALR3
- EPAS1
- CSTA
- COT2
- YAP1
Cross-references
Synonyms
- Convallatoxigenin
- Strophanthidine
- Corchsularin
- Corchorgenin
- Erysimupicrone
- Corchoside A aglycon
- K Strophanthidin
- Corchorin
- Strophanthidin K
- Erysimupikron
- Cymarigenin
- Apocymarin
- 5beta-Hydroxy-19-oxodigitoxigenin
- NSC 86078
- 3beta,5,14-Trihydroxy-19-oxo-5beta-card-20(22)-enolide
- CHEBI:38178
- W5O632DN33
- (3beta,5beta)-3,5,14-Trihydroxy-19-oxocard-20(22)-enolide
- 5beta-Card-20(22)-enolide, 3beta,5,14-trihydroxy-19-oxo-
- KStrophanthidin
- RefChem:389291
- DTXCID001331905
- Apocynamarin
- k-Strophanthidine
- Cynotoxin
- Antibiotic XS-89
- NSC86078
- MLS002153969
- XS-89
- Strophantidine
- 3,5,14-Trihydroxy-19-oxocard-20(22)-enolide
- 5-beta-Hydroxy-19-oxodigitoxigenin
- MLS002701929
- EINECS 200-626-6
- BRN 0097859
- UNII-W5O632DN33
- 5.beta.-Hydroxy-19-oxodigitoxigenin
Look up STROPHANTHIDIN in the interactive SynDRA portal →